Proteomics refers to the large-scale study of proteins, particularly their structures and functions. Proteomics plays an important role in understanding disease pathways and discovering clinically-relevant biomarkers for diagnostics and discovering drug targets. It has applications in various fields such as determining protein-protein interactions, identifying biomarkers for disease diagnosis, identifying post-translational modifications, and understanding disease mechanisms. Proteomics studies are aiding discovery efforts for various diseases including cancer, cardiovascular diseases, neurological disorders, and infectious diseases. The global proteomics market is estimated to be valued at US$ 36.8 Bn in 2024 and is expected to exhibit a CAGR of 19% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Dynamics:

Rising Demand for Disease Diagnosis: Proteomics plays a significant role in discovering protein-based biomarkers for the diagnosis of various diseases. It aids in early disease diagnosis, disease monitoring, and treatment response assessments. Biomarker discovery through proteomics tools is accelerating the progress of precision medicine. The rising incidence of chronic and complex diseases worldwide is fueling the demand for proteomics in biomarker discovery and disease diagnosis.

Increasing Research Activity in Proteomics: There has been significant growth in research utilizing proteomics tools over the past decade. Pharmaceutical and biotech companies are increasingly adopting proteomics techniques to accelerate drug target discovery and preclinical research. Government support in terms of funding for proteomics research is also promoting advancements in proteomics tools and technologies. These factors are driving the growth of the global proteomics market.

SWOT Analysis
Strength: Proteomics helps in disease diagnosis and drug development. It can accelerate discovery of biomarkers for detection and prognosis of diseases like cancer. Profiling proteins helps understand biological processes better. Another advantage is proteomics techniques are advancing rapidly to provide more sensitive and quantitative analysis of thousands of proteins simultaneously.

Weakness: Proteomic analysis is technically challenging compared to genomics due to dynamic range and complexity of the proteome. Sample preparation and data analysis require specialized expertise and infrastructure. Quantification of low abundance proteins still remains difficult.

Opportunity: Application of proteomics in precision medicine offers potential for development of new diagnostic tests and targeted therapies. Growing interest in finding disease biomarkers and surrogates for drug development is boosting proteomics adoption. Combining proteomics with other omics techniques can provide deeper insights into molecular mechanisms.

Threats: High costs of instruments, reagents and data analysis services pose affordability challenges for widespread clinical use presently. Complex regulatory approvals also delay translation and commercialization of proteomics enabled tools. Lack of standardized protocols and expertise are other bottlenecks for growth.

Key Takeaways
The global Proteomics Market Share is expected to witness high growth over the forecast period driven by ongoing development of advanced technologies.

Regional analysis: North America accounts for the largest share of the proteomics market primarily due to availability of funding through government and private organizations. However, Asia Pacific region is anticipated to witness the highest CAGR during the forecast period owing to rising investments in proteomics research programs by institutes like National Centre for Cell Science India and Shanghai Center for Proteome Research China. Strong economic growth in India and China are supplementing the regional market growth.

Key players operating in the proteomics market are Thermo Fisher Scientific Inc., Danaher Corporation, Bio-Rad Laboratories, Inc., Agilent Technologies, Bruker Corporation, GE Healthcare, Merck KGaA, Waters Corporation, Luminex Corporation, PerkinElmer. Thermo Fisher and Danaher are the leaders in proteomics instruments, reagents and software for research and diagnostics applications globally and occupy majority market share.

For more insights, read- https://www.pressreleasebulletin.com/proteomics-market-trends-size-and-share-analysis/

For more details on the report,  Read- https://careersplay.com/the-rising-trend-of-biohacking-and-its-opportunities